Advanced search
Publication Cover
Journal of Medical Economics Volume 16, 2013 - Issue 9
Submit an article Journal homepage
744
Views
3
CrossRef citations to date
0
Altmetric
Original Articles

Cost per responder analysis in patients with secondary hyperparathyroidism on dialysis treated with cinacalcet

Vasily BelozeroffAmgen Inc. Thousand Oaks, CAUSACorrespondence[email protected]
,
Andrew LeeAmgen Inc. Thousand Oaks, CAUSA
,
Spring TsengAmgen Inc. San Francisco, CAUSA
,
Silvia ChiroliAmgen Inc. ZugSwitzerland
&
Jonathan D. CampbellUniversity of Colorado Aurora, COUSA
Pages 1154-1162 | Accepted 16 Jul 2013, Published online: 06 Aug 2013

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Marjan Massoudi, Mark Balk, Hongbo Yang, Cat N. Bui, Bhavik J. Pandya, Jenny Guo, Yan Song, Eric Q. Wu, Bruce Brown, Arie Barlev & Scott Flanders. (2017) Number needed to treat and associated incremental costs of treatment with enzalutamide versus abiraterone acetate plus prednisone in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer. Journal of Medical Economics 20:2, pages 121-128.
Read now
Valentina Lorenzoni, Leopoldo Trieste & Giuseppe Turchetti. (2015) The cost–effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 611-624.
Read now

Articles from other publishers (1)

Guoqi Wang, Hongyan Liu, Chengzhi Wang, Xiaojian Ji, Weijun Gu & Yiming Mu. (2018) Cinacalcet versus Placebo for secondary hyperparathyroidism in chronic kidney disease patients: a meta-analysis of randomized controlled trials and trial sequential analysis. Scientific Reports 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.